The Highly Potent & Oncology platform offers over 30 years of experience in the development and production of highly potent compounds. Our extensive capabilities enable us to support your project from clinical through commercialization.
Our API facilities can scale-up from laboratory-scale to 12,000 L vessels. The Oral Solid Dosage Drug Product manufacturing capabilities start with 100 g of blend, and gradually increase according to the demand of your project, while our commercial injectable Drug Product facility can aseptically manufacture cytotoxic & cytostatic filled vials (lyophilized & liquid fill).
This continuum of capabilities from APIs to finished dosage Drug Products, including ready-for-market packaging, labelling and serialization, allows you to either pick and choose required services, or take advantage of our Integrated Supply chain from development to commercialization. The level of integration is flexible and customizable, resulting in reduced complexity, de-risked supply chain and shorter lead-times. We deliver agile and innovative solutions to meet your current and future needs.